From Pharma To Health Tech Ceo: Using Data To Overhaul The Specialty Drug Industry Interview with Pramod John, CEO, Vivio Health

Driven by a personal passion to change healthcare and “the obligation to do the right thing for the good of every American,” Pramod John, CEO of Vivio Health, is on a mission to overhaul the specialty drug market.

He and the team at Vivio - founded by a leaders previously working in Pharma - want to use data to help people get the right drug, at the right time. 

Pramod says medications are the most frequent intervention a physician will make, and that specialty drugs are the fastest growing segment of healthcare globally. 

Yet, he also says that many of the drugs aren’t widely effective. 

The team of Vivio sees opportunity for change and is working to improve things by using and analyzing real-world drug and patient data - analyzed separately from the FDA.

Learn more about Vivio Health: https://viviohealth.com 

Connect with Pramod: https://www.linkedin.com/in/pramod-john/ 

Topical time codes:

00:00 - Video starts

00:58 - Creation of Vivio Health

2:28 - Specialty drug market

5:15 - Endorsement of specialty drugs by influencers and celebs

8:04 - Lack of time to analyze drug trial info of every new drug

12:08 - Too much info for physicians to keep up with in practice, no infrastructure to help 

14:56 - Using computers to keep up with data doesn’t mean human replacement - they’re good at different things 

17:26 - Switch in thinking to allow change and let people work at their highest level

20:56 - Using technology more often and using it better

23:36 - Personal passion for change